enfortumab,Pembrolizumab,cisplatin,carboplatin,gemcitabine
Astellas,Merck,Seagen
['urothelial carcinoma', 'urothelial', 'enfortumab', 'pembro', 'blcsm', ' vedo']
enfortumab vedotin plus pembrolizumab produces durable responses, safety in metastatic urothelial carcinoma #asco23 #blcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.